EcoActive

AXP000225.1 · Phage therapy

Platform
phage cocktail (non-engineered)
Originator
Intralytix
Sponsor
Intralytix

Names

NameTypeSource
EcoActivepreferred name, codecurator, ctgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
Escherichia coli bacteriophage (cocktail)
Replication
replicating
Route
oral
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT03808103Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's DiseaseActive not recruitingPhase 1/22019-05-012026-06-0130Crohn Disease

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 33310655Enhancing phage therapy through synthetic biology and genome engineering.Current opinion in biotechnology2021cited by trial NCT03808103

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 39587720Comparison of Crohn's disease-associated adherent-invasive Escherichia coli (AIEC) from France and Hong Kong: results from the Pacific study.Gut microbes2024name in abstract: EcoActive
PMID 35997152Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.Journal of Crohn's & colitis2022name in abstract: EcoActive
PMID 31649628Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere.Frontiers in microbiology2019name in title: EcoActive

Notes

Oral phage preparation against adherent-invasive Escherichia coli (AIEC) in Crohn's disease. Phase 1/2a NCT03808103 with Mount Sinai and Johns Hopkins.

How to cite

EcoActive (AXP000225.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000225.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.